Postmenopausal women living in a high radon zone have significantly higher risks for ovarian cancer incidence and mortality, ...

Radon already has a well-earned reputation as a lung cancer threat. Now a systematic review published in Frontiers in Public ...

Sofetabart mipitecan (LY4170156), an investigational folate receptor alpha (FRα)-targeted antibody-drug conjugate (ADC), elicited strong antitumor activity in patients with recurrent ...

Volastra Therapeutics, a clinical-stage oncology company pioneering therapies targeting chromosomal instability (CIN), today ...

A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

This renewed focus comes as experts, such as Dr Jane Benjamin, GP and women’s health lead at HCA UK Primary Care, continue to highlight crucial health red flags women should never disregard.

Health Secretary Wes Streeting has reaffirmed his commitment to improving women’s healthcare on the NHS with a refreshed ...

New real-world data from the 1INSPIRE study shows that frontline niraparib (Zejula) maintenance is well-tolerated in patients ...

The clinical presentation of gastrointestinal stromal tumours (GISTs) can vary and can be attributed to tumour mass effect or gastrointestinal haemorrhage. We present the rare case of a female in her ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

Rezatapopt is a first-in-class oral therapy designed to target the TP53 Y220C mutation. This mutation affects the p53 protein ...

At SGO 2026, Alison Schram, MD, highlighted first-in-class tumor suppressor reactivation and emphasized early NGS testing in ...